Inogen Inc. entered into an Asset Purchase Agreement with Rotech Healthcare Inc. to sell substantially all assets related to its U.S. oxygen rental business for up to $24.8 million, payable in six installments subject to post-closing reconciliation. The transaction is expected to close in the fourth quarter of 2026 and includes a separate long-term product supply agreement with Rotech. Concurrently, Inogen’s Board approved an amendment to its share repurchase program, increasing the total authorization from $30.0 million to $45.0 million and extending the expiration date to June 30, 2028, contingent upon the closing of the divestiture. The company expects the Rental Business to be classified as discontinued operations starting in the third quarter of 2026. Inogen Inc. is a medical technology company that develops, manufactures, and markets innovative respiratory therapy devices for homecare settings.
